nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Carmustine—melanoma	0.24	0.417	CbGbCtD
Frovatriptan—CYP1A2—Vemurafenib—melanoma	0.189	0.33	CbGbCtD
Frovatriptan—CYP1A2—Dacarbazine—melanoma	0.145	0.253	CbGbCtD
Frovatriptan—HTR1D—meninx—melanoma	0.0496	0.72	CbGeAlD
Frovatriptan—HTR1B—blood vessel—melanoma	0.00581	0.0844	CbGeAlD
Frovatriptan—HTR1D—blood vessel—melanoma	0.00562	0.0817	CbGeAlD
Frovatriptan—HTR1D—eye—melanoma	0.00299	0.0435	CbGeAlD
Frovatriptan—HTR1B—head—melanoma	0.00175	0.0255	CbGeAlD
Frovatriptan—HTR1D—head—melanoma	0.0017	0.0247	CbGeAlD
Frovatriptan—Eye pain—Carmustine—melanoma	0.00158	0.00565	CcSEcCtD
Frovatriptan—Back pain—Vemurafenib—melanoma	0.00157	0.00562	CcSEcCtD
Frovatriptan—Myocardial ischaemia—Docetaxel—melanoma	0.00157	0.00561	CcSEcCtD
Frovatriptan—Rigors—Docetaxel—melanoma	0.00154	0.00553	CcSEcCtD
Frovatriptan—Vascular purpura—Temozolomide—melanoma	0.00154	0.00551	CcSEcCtD
Frovatriptan—Eye pain—Temozolomide—melanoma	0.00152	0.00546	CcSEcCtD
Frovatriptan—Amnesia—Carmustine—melanoma	0.00151	0.00543	CcSEcCtD
Frovatriptan—Hot flush—Temozolomide—melanoma	0.00147	0.00527	CcSEcCtD
Frovatriptan—Amnesia—Temozolomide—melanoma	0.00146	0.00524	CcSEcCtD
Frovatriptan—Menopausal symptoms—Temozolomide—melanoma	0.00146	0.00522	CcSEcCtD
Frovatriptan—Thirst—Temozolomide—melanoma	0.00144	0.00518	CcSEcCtD
Frovatriptan—Purpura—Temozolomide—melanoma	0.00143	0.00511	CcSEcCtD
Frovatriptan—Chest discomfort—Docetaxel—melanoma	0.00142	0.0051	CcSEcCtD
Frovatriptan—HTR1A—head—melanoma	0.00142	0.0206	CbGeAlD
Frovatriptan—Arthralgia—Vemurafenib—melanoma	0.00138	0.00494	CcSEcCtD
Frovatriptan—Myalgia—Vemurafenib—melanoma	0.00138	0.00494	CcSEcCtD
Frovatriptan—Affect lability—Temozolomide—melanoma	0.00135	0.00485	CcSEcCtD
Frovatriptan—Ataxia—Carmustine—melanoma	0.00134	0.00479	CcSEcCtD
Frovatriptan—Anaphylactic shock—Vemurafenib—melanoma	0.00132	0.00474	CcSEcCtD
Frovatriptan—Bone pain—Docetaxel—melanoma	0.00132	0.00471	CcSEcCtD
Frovatriptan—Dysphagia—Dactinomycin—melanoma	0.00131	0.00471	CcSEcCtD
Frovatriptan—Mood swings—Temozolomide—melanoma	0.0013	0.00467	CcSEcCtD
Frovatriptan—Ataxia—Temozolomide—melanoma	0.00129	0.00463	CcSEcCtD
Frovatriptan—Dehydration—Temozolomide—melanoma	0.00128	0.00458	CcSEcCtD
Frovatriptan—Muscular weakness—Carmustine—melanoma	0.00126	0.0045	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Bleomycin—melanoma	0.00124	0.00444	CcSEcCtD
Frovatriptan—Myocardial infarction—Bleomycin—melanoma	0.00123	0.00441	CcSEcCtD
Frovatriptan—Dysphagia—Carmustine—melanoma	0.00123	0.00441	CcSEcCtD
Frovatriptan—Stomatitis—Bleomycin—melanoma	0.00122	0.00439	CcSEcCtD
Frovatriptan—Muscular weakness—Temozolomide—melanoma	0.00121	0.00435	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0012	0.00432	CcSEcCtD
Frovatriptan—Dysphagia—Temozolomide—melanoma	0.00119	0.00426	CcSEcCtD
Frovatriptan—Sweating increased—Temozolomide—melanoma	0.00116	0.00415	CcSEcCtD
Frovatriptan—Decreased appetite—Vemurafenib—melanoma	0.00115	0.00412	CcSEcCtD
Frovatriptan—Stomatitis—Dactinomycin—melanoma	0.00114	0.00409	CcSEcCtD
Frovatriptan—Fatigue—Vemurafenib—melanoma	0.00114	0.00408	CcSEcCtD
Frovatriptan—Haemoglobin—Bleomycin—melanoma	0.00113	0.00406	CcSEcCtD
Frovatriptan—Constipation—Vemurafenib—melanoma	0.00113	0.00405	CcSEcCtD
Frovatriptan—Haemorrhage—Bleomycin—melanoma	0.00113	0.00404	CcSEcCtD
Frovatriptan—Hypoaesthesia—Bleomycin—melanoma	0.00112	0.00402	CcSEcCtD
Frovatriptan—Pollakiuria—Temozolomide—melanoma	0.0011	0.00393	CcSEcCtD
Frovatriptan—Depression—Carmustine—melanoma	0.00109	0.00392	CcSEcCtD
Frovatriptan—Stomatitis—Carmustine—melanoma	0.00107	0.00383	CcSEcCtD
Frovatriptan—Depression—Temozolomide—melanoma	0.00106	0.00379	CcSEcCtD
Frovatriptan—Flushing—Bleomycin—melanoma	0.00105	0.00375	CcSEcCtD
Frovatriptan—Body temperature increased—Vemurafenib—melanoma	0.00105	0.00375	CcSEcCtD
Frovatriptan—Pharyngitis—Dactinomycin—melanoma	0.00104	0.00374	CcSEcCtD
Frovatriptan—Stomatitis—Temozolomide—melanoma	0.00103	0.0037	CcSEcCtD
Frovatriptan—Chills—Bleomycin—melanoma	0.00101	0.00363	CcSEcCtD
Frovatriptan—Sinusitis—Temozolomide—melanoma	0.000994	0.00356	CcSEcCtD
Frovatriptan—Haemoglobin—Carmustine—melanoma	0.000989	0.00354	CcSEcCtD
Frovatriptan—Haemorrhage—Carmustine—melanoma	0.000984	0.00353	CcSEcCtD
Frovatriptan—Hypoaesthesia—Carmustine—melanoma	0.000979	0.00351	CcSEcCtD
Frovatriptan—Hot flush—Docetaxel—melanoma	0.000978	0.0035	CcSEcCtD
Frovatriptan—Flushing—Dactinomycin—melanoma	0.000976	0.0035	CcSEcCtD
Frovatriptan—Hypersensitivity—Vemurafenib—melanoma	0.000974	0.00349	CcSEcCtD
Frovatriptan—Menopausal symptoms—Docetaxel—melanoma	0.000969	0.00347	CcSEcCtD
Frovatriptan—Dermatitis bullous—Docetaxel—melanoma	0.000957	0.00343	CcSEcCtD
Frovatriptan—Haemoglobin—Temozolomide—melanoma	0.000956	0.00343	CcSEcCtD
Frovatriptan—Haemorrhage—Temozolomide—melanoma	0.000951	0.00341	CcSEcCtD
Frovatriptan—Asthenia—Vemurafenib—melanoma	0.000949	0.0034	CcSEcCtD
Frovatriptan—Visual impairment—Carmustine—melanoma	0.000949	0.0034	CcSEcCtD
Frovatriptan—Hypoaesthesia—Temozolomide—melanoma	0.000947	0.00339	CcSEcCtD
Frovatriptan—Pharyngitis—Temozolomide—melanoma	0.000944	0.00338	CcSEcCtD
Frovatriptan—Chills—Dactinomycin—melanoma	0.000944	0.00338	CcSEcCtD
Frovatriptan—Urinary tract disorder—Temozolomide—melanoma	0.000939	0.00337	CcSEcCtD
Frovatriptan—Pruritus—Vemurafenib—melanoma	0.000936	0.00335	CcSEcCtD
Frovatriptan—Urethral disorder—Temozolomide—melanoma	0.000933	0.00334	CcSEcCtD
Frovatriptan—Visual impairment—Temozolomide—melanoma	0.000917	0.00328	CcSEcCtD
Frovatriptan—Pain in extremity—Docetaxel—melanoma	0.000914	0.00328	CcSEcCtD
Frovatriptan—Flushing—Carmustine—melanoma	0.000914	0.00327	CcSEcCtD
Frovatriptan—Ill-defined disorder—Bleomycin—melanoma	0.000911	0.00326	CcSEcCtD
Frovatriptan—Diarrhoea—Vemurafenib—melanoma	0.000905	0.00324	CcSEcCtD
Frovatriptan—Migraine—Docetaxel—melanoma	0.0009	0.00322	CcSEcCtD
Frovatriptan—Tinnitus—Temozolomide—melanoma	0.000887	0.00318	CcSEcCtD
Frovatriptan—Malaise—Bleomycin—melanoma	0.000885	0.00317	CcSEcCtD
Frovatriptan—Flushing—Temozolomide—melanoma	0.000883	0.00316	CcSEcCtD
Frovatriptan—Arrhythmia—Carmustine—melanoma	0.000879	0.00315	CcSEcCtD
Frovatriptan—Dizziness—Vemurafenib—melanoma	0.000875	0.00313	CcSEcCtD
Frovatriptan—Mental disorder—Carmustine—melanoma	0.000862	0.00309	CcSEcCtD
Frovatriptan—Ataxia—Docetaxel—melanoma	0.00086	0.00308	CcSEcCtD
Frovatriptan—Malnutrition—Carmustine—melanoma	0.000857	0.00307	CcSEcCtD
Frovatriptan—Chills—Temozolomide—melanoma	0.000854	0.00306	CcSEcCtD
Frovatriptan—Dehydration—Docetaxel—melanoma	0.00085	0.00305	CcSEcCtD
Frovatriptan—Ill-defined disorder—Dactinomycin—melanoma	0.00085	0.00304	CcSEcCtD
Frovatriptan—Vomiting—Vemurafenib—melanoma	0.000841	0.00301	CcSEcCtD
Frovatriptan—Chest pain—Bleomycin—melanoma	0.000836	0.00299	CcSEcCtD
Frovatriptan—Myalgia—Bleomycin—melanoma	0.000836	0.00299	CcSEcCtD
Frovatriptan—Mental disorder—Temozolomide—melanoma	0.000833	0.00299	CcSEcCtD
Frovatriptan—Back pain—Carmustine—melanoma	0.000829	0.00297	CcSEcCtD
Frovatriptan—Headache—Vemurafenib—melanoma	0.000828	0.00297	CcSEcCtD
Frovatriptan—Malnutrition—Temozolomide—melanoma	0.000828	0.00297	CcSEcCtD
Frovatriptan—Discomfort—Bleomycin—melanoma	0.000826	0.00296	CcSEcCtD
Frovatriptan—Malaise—Dactinomycin—melanoma	0.000826	0.00296	CcSEcCtD
Frovatriptan—Dysgeusia—Temozolomide—melanoma	0.000811	0.00291	CcSEcCtD
Frovatriptan—Confusional state—Bleomycin—melanoma	0.000808	0.00289	CcSEcCtD
Frovatriptan—Tremor—Carmustine—melanoma	0.000803	0.00288	CcSEcCtD
Frovatriptan—Anaphylactic shock—Bleomycin—melanoma	0.000801	0.00287	CcSEcCtD
Frovatriptan—Back pain—Temozolomide—melanoma	0.000801	0.00287	CcSEcCtD
Frovatriptan—Dysphagia—Docetaxel—melanoma	0.00079	0.00283	CcSEcCtD
Frovatriptan—Agitation—Carmustine—melanoma	0.000788	0.00282	CcSEcCtD
Frovatriptan—Nausea—Vemurafenib—melanoma	0.000786	0.00281	CcSEcCtD
Frovatriptan—Myalgia—Dactinomycin—melanoma	0.00078	0.00279	CcSEcCtD
Frovatriptan—Tremor—Temozolomide—melanoma	0.000776	0.00278	CcSEcCtD
Frovatriptan—Discomfort—Dactinomycin—melanoma	0.00077	0.00276	CcSEcCtD
Frovatriptan—Ill-defined disorder—Temozolomide—melanoma	0.000768	0.00275	CcSEcCtD
Frovatriptan—Anorexia—Bleomycin—melanoma	0.000764	0.00274	CcSEcCtD
Frovatriptan—Agitation—Temozolomide—melanoma	0.000761	0.00273	CcSEcCtD
Frovatriptan—Malaise—Temozolomide—melanoma	0.000747	0.00268	CcSEcCtD
Frovatriptan—Vertigo—Temozolomide—melanoma	0.000744	0.00267	CcSEcCtD
Frovatriptan—Convulsion—Carmustine—melanoma	0.000742	0.00266	CcSEcCtD
Frovatriptan—Palpitations—Temozolomide—melanoma	0.000732	0.00262	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Bleomycin—melanoma	0.00073	0.00262	CcSEcCtD
Frovatriptan—Chest pain—Carmustine—melanoma	0.00073	0.00261	CcSEcCtD
Frovatriptan—Myalgia—Carmustine—melanoma	0.00073	0.00261	CcSEcCtD
Frovatriptan—Anxiety—Carmustine—melanoma	0.000727	0.0026	CcSEcCtD
Frovatriptan—Paraesthesia—Bleomycin—melanoma	0.000719	0.00258	CcSEcCtD
Frovatriptan—Convulsion—Temozolomide—melanoma	0.000718	0.00257	CcSEcCtD
Frovatriptan—Dyspnoea—Bleomycin—melanoma	0.000714	0.00256	CcSEcCtD
Frovatriptan—Anorexia—Dactinomycin—melanoma	0.000712	0.00255	CcSEcCtD
Frovatriptan—Confusional state—Carmustine—melanoma	0.000705	0.00253	CcSEcCtD
Frovatriptan—Myalgia—Temozolomide—melanoma	0.000705	0.00253	CcSEcCtD
Frovatriptan—Arthralgia—Temozolomide—melanoma	0.000705	0.00253	CcSEcCtD
Frovatriptan—Anxiety—Temozolomide—melanoma	0.000703	0.00252	CcSEcCtD
Frovatriptan—Discomfort—Temozolomide—melanoma	0.000697	0.0025	CcSEcCtD
Frovatriptan—Decreased appetite—Bleomycin—melanoma	0.000697	0.0025	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Docetaxel—melanoma	0.000695	0.00249	CcSEcCtD
Frovatriptan—Myocardial infarction—Docetaxel—melanoma	0.000691	0.00247	CcSEcCtD
Frovatriptan—Dry mouth—Temozolomide—melanoma	0.00069	0.00247	CcSEcCtD
Frovatriptan—Stomatitis—Docetaxel—melanoma	0.000687	0.00246	CcSEcCtD
Frovatriptan—Pain—Bleomycin—melanoma	0.000685	0.00245	CcSEcCtD
Frovatriptan—Conjunctivitis—Docetaxel—melanoma	0.000685	0.00245	CcSEcCtD
Frovatriptan—Tachycardia—Carmustine—melanoma	0.000683	0.00245	CcSEcCtD
Frovatriptan—Confusional state—Temozolomide—melanoma	0.000681	0.00244	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000681	0.00244	CcSEcCtD
Frovatriptan—Anaphylactic shock—Temozolomide—melanoma	0.000676	0.00242	CcSEcCtD
Frovatriptan—Anorexia—Carmustine—melanoma	0.000667	0.00239	CcSEcCtD
Frovatriptan—Epistaxis—Docetaxel—melanoma	0.000665	0.00238	CcSEcCtD
Frovatriptan—Feeling abnormal—Bleomycin—melanoma	0.00066	0.00237	CcSEcCtD
Frovatriptan—Hyperhidrosis—Temozolomide—melanoma	0.000653	0.00234	CcSEcCtD
Frovatriptan—Decreased appetite—Dactinomycin—melanoma	0.00065	0.00233	CcSEcCtD
Frovatriptan—Fatigue—Dactinomycin—melanoma	0.000644	0.00231	CcSEcCtD
Frovatriptan—Anorexia—Temozolomide—melanoma	0.000644	0.00231	CcSEcCtD
Frovatriptan—Pain—Dactinomycin—melanoma	0.000639	0.00229	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Carmustine—melanoma	0.000637	0.00228	CcSEcCtD
Frovatriptan—Haemoglobin—Docetaxel—melanoma	0.000636	0.00228	CcSEcCtD
Frovatriptan—Rhinitis—Docetaxel—melanoma	0.000634	0.00227	CcSEcCtD
Frovatriptan—Body temperature increased—Bleomycin—melanoma	0.000633	0.00227	CcSEcCtD
Frovatriptan—Haemorrhage—Docetaxel—melanoma	0.000633	0.00227	CcSEcCtD
Frovatriptan—Insomnia—Carmustine—melanoma	0.000633	0.00227	CcSEcCtD
Frovatriptan—Hypoaesthesia—Docetaxel—melanoma	0.000629	0.00226	CcSEcCtD
Frovatriptan—Paraesthesia—Carmustine—melanoma	0.000628	0.00225	CcSEcCtD
Frovatriptan—Pharyngitis—Docetaxel—melanoma	0.000628	0.00225	CcSEcCtD
Frovatriptan—Urinary tract disorder—Docetaxel—melanoma	0.000625	0.00224	CcSEcCtD
Frovatriptan—Dyspnoea—Carmustine—melanoma	0.000624	0.00223	CcSEcCtD
Frovatriptan—Somnolence—Carmustine—melanoma	0.000622	0.00223	CcSEcCtD
Frovatriptan—Urethral disorder—Docetaxel—melanoma	0.00062	0.00222	CcSEcCtD
Frovatriptan—Feeling abnormal—Dactinomycin—melanoma	0.000616	0.00221	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000616	0.00221	CcSEcCtD
Frovatriptan—Insomnia—Temozolomide—melanoma	0.000611	0.00219	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Dactinomycin—melanoma	0.000611	0.00219	CcSEcCtD
Frovatriptan—Visual impairment—Docetaxel—melanoma	0.00061	0.00218	CcSEcCtD
Frovatriptan—Decreased appetite—Carmustine—melanoma	0.000608	0.00218	CcSEcCtD
Frovatriptan—Paraesthesia—Temozolomide—melanoma	0.000607	0.00217	CcSEcCtD
Frovatriptan—Dyspnoea—Temozolomide—melanoma	0.000603	0.00216	CcSEcCtD
Frovatriptan—Somnolence—Temozolomide—melanoma	0.000601	0.00215	CcSEcCtD
Frovatriptan—Constipation—Carmustine—melanoma	0.000598	0.00214	CcSEcCtD
Frovatriptan—Pain—Carmustine—melanoma	0.000598	0.00214	CcSEcCtD
Frovatriptan—Dyspepsia—Temozolomide—melanoma	0.000595	0.00213	CcSEcCtD
Frovatriptan—Abdominal pain—Dactinomycin—melanoma	0.000591	0.00212	CcSEcCtD
Frovatriptan—Body temperature increased—Dactinomycin—melanoma	0.000591	0.00212	CcSEcCtD
Frovatriptan—Hypersensitivity—Bleomycin—melanoma	0.00059	0.00211	CcSEcCtD
Frovatriptan—Decreased appetite—Temozolomide—melanoma	0.000588	0.0021	CcSEcCtD
Frovatriptan—Flushing—Docetaxel—melanoma	0.000587	0.0021	CcSEcCtD
Frovatriptan—Fatigue—Temozolomide—melanoma	0.000583	0.00209	CcSEcCtD
Frovatriptan—Pain—Temozolomide—melanoma	0.000578	0.00207	CcSEcCtD
Frovatriptan—Constipation—Temozolomide—melanoma	0.000578	0.00207	CcSEcCtD
Frovatriptan—Feeling abnormal—Carmustine—melanoma	0.000576	0.00206	CcSEcCtD
Frovatriptan—Asthenia—Bleomycin—melanoma	0.000575	0.00206	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Carmustine—melanoma	0.000572	0.00205	CcSEcCtD
Frovatriptan—Chills—Docetaxel—melanoma	0.000568	0.00203	CcSEcCtD
Frovatriptan—Pruritus—Bleomycin—melanoma	0.000567	0.00203	CcSEcCtD
Frovatriptan—Arrhythmia—Docetaxel—melanoma	0.000565	0.00202	CcSEcCtD
Frovatriptan—Feeling abnormal—Temozolomide—melanoma	0.000557	0.002	CcSEcCtD
Frovatriptan—Mental disorder—Docetaxel—melanoma	0.000554	0.00199	CcSEcCtD
Frovatriptan—Body temperature increased—Carmustine—melanoma	0.000553	0.00198	CcSEcCtD
Frovatriptan—Abdominal pain—Carmustine—melanoma	0.000553	0.00198	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Temozolomide—melanoma	0.000553	0.00198	CcSEcCtD
Frovatriptan—Malnutrition—Docetaxel—melanoma	0.000551	0.00197	CcSEcCtD
Frovatriptan—Hypersensitivity—Dactinomycin—melanoma	0.000551	0.00197	CcSEcCtD
Frovatriptan—Dysgeusia—Docetaxel—melanoma	0.000539	0.00193	CcSEcCtD
Frovatriptan—Asthenia—Dactinomycin—melanoma	0.000536	0.00192	CcSEcCtD
Frovatriptan—Abdominal pain—Temozolomide—melanoma	0.000534	0.00191	CcSEcCtD
Frovatriptan—Body temperature increased—Temozolomide—melanoma	0.000534	0.00191	CcSEcCtD
Frovatriptan—Back pain—Docetaxel—melanoma	0.000533	0.00191	CcSEcCtD
Frovatriptan—Muscle spasms—Docetaxel—melanoma	0.000529	0.0019	CcSEcCtD
Frovatriptan—Hypersensitivity—Carmustine—melanoma	0.000515	0.00185	CcSEcCtD
Frovatriptan—Diarrhoea—Dactinomycin—melanoma	0.000511	0.00183	CcSEcCtD
Frovatriptan—Vomiting—Bleomycin—melanoma	0.000509	0.00183	CcSEcCtD
Frovatriptan—Asthenia—Carmustine—melanoma	0.000502	0.0018	CcSEcCtD
Frovatriptan—Hypersensitivity—Temozolomide—melanoma	0.000498	0.00178	CcSEcCtD
Frovatriptan—Syncope—Docetaxel—melanoma	0.000494	0.00177	CcSEcCtD
Frovatriptan—Palpitations—Docetaxel—melanoma	0.000487	0.00174	CcSEcCtD
Frovatriptan—Asthenia—Temozolomide—melanoma	0.000485	0.00174	CcSEcCtD
Frovatriptan—Loss of consciousness—Docetaxel—melanoma	0.000484	0.00173	CcSEcCtD
Frovatriptan—Diarrhoea—Carmustine—melanoma	0.000479	0.00171	CcSEcCtD
Frovatriptan—Pruritus—Temozolomide—melanoma	0.000478	0.00171	CcSEcCtD
Frovatriptan—Convulsion—Docetaxel—melanoma	0.000477	0.00171	CcSEcCtD
Frovatriptan—Nausea—Bleomycin—melanoma	0.000476	0.00171	CcSEcCtD
Frovatriptan—Vomiting—Dactinomycin—melanoma	0.000475	0.0017	CcSEcCtD
Frovatriptan—Chest pain—Docetaxel—melanoma	0.000469	0.00168	CcSEcCtD
Frovatriptan—Arthralgia—Docetaxel—melanoma	0.000469	0.00168	CcSEcCtD
Frovatriptan—Myalgia—Docetaxel—melanoma	0.000469	0.00168	CcSEcCtD
Frovatriptan—Dizziness—Carmustine—melanoma	0.000462	0.00166	CcSEcCtD
Frovatriptan—Diarrhoea—Temozolomide—melanoma	0.000462	0.00166	CcSEcCtD
Frovatriptan—Dry mouth—Docetaxel—melanoma	0.000459	0.00164	CcSEcCtD
Frovatriptan—Confusional state—Docetaxel—melanoma	0.000453	0.00162	CcSEcCtD
Frovatriptan—Anaphylactic shock—Docetaxel—melanoma	0.000449	0.00161	CcSEcCtD
Frovatriptan—Dizziness—Temozolomide—melanoma	0.000447	0.0016	CcSEcCtD
Frovatriptan—Vomiting—Carmustine—melanoma	0.000445	0.00159	CcSEcCtD
Frovatriptan—Nausea—Dactinomycin—melanoma	0.000444	0.00159	CcSEcCtD
Frovatriptan—Shock—Docetaxel—melanoma	0.000442	0.00158	CcSEcCtD
Frovatriptan—Tachycardia—Docetaxel—melanoma	0.000439	0.00157	CcSEcCtD
Frovatriptan—Headache—Carmustine—melanoma	0.000438	0.00157	CcSEcCtD
Frovatriptan—Vomiting—Temozolomide—melanoma	0.00043	0.00154	CcSEcCtD
Frovatriptan—Anorexia—Docetaxel—melanoma	0.000428	0.00153	CcSEcCtD
Frovatriptan—Headache—Temozolomide—melanoma	0.000423	0.00152	CcSEcCtD
Frovatriptan—Nausea—Carmustine—melanoma	0.000415	0.00149	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000409	0.00147	CcSEcCtD
Frovatriptan—Insomnia—Docetaxel—melanoma	0.000407	0.00146	CcSEcCtD
Frovatriptan—Paraesthesia—Docetaxel—melanoma	0.000404	0.00145	CcSEcCtD
Frovatriptan—Nausea—Temozolomide—melanoma	0.000401	0.00144	CcSEcCtD
Frovatriptan—Dyspnoea—Docetaxel—melanoma	0.000401	0.00144	CcSEcCtD
Frovatriptan—Somnolence—Docetaxel—melanoma	0.0004	0.00143	CcSEcCtD
Frovatriptan—Dyspepsia—Docetaxel—melanoma	0.000396	0.00142	CcSEcCtD
Frovatriptan—Decreased appetite—Docetaxel—melanoma	0.000391	0.0014	CcSEcCtD
Frovatriptan—Fatigue—Docetaxel—melanoma	0.000388	0.00139	CcSEcCtD
Frovatriptan—Pain—Docetaxel—melanoma	0.000384	0.00138	CcSEcCtD
Frovatriptan—Constipation—Docetaxel—melanoma	0.000384	0.00138	CcSEcCtD
Frovatriptan—Feeling abnormal—Docetaxel—melanoma	0.00037	0.00133	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Docetaxel—melanoma	0.000368	0.00132	CcSEcCtD
Frovatriptan—Body temperature increased—Docetaxel—melanoma	0.000355	0.00127	CcSEcCtD
Frovatriptan—Abdominal pain—Docetaxel—melanoma	0.000355	0.00127	CcSEcCtD
Frovatriptan—Hypersensitivity—Docetaxel—melanoma	0.000331	0.00119	CcSEcCtD
Frovatriptan—Asthenia—Docetaxel—melanoma	0.000322	0.00116	CcSEcCtD
Frovatriptan—Pruritus—Docetaxel—melanoma	0.000318	0.00114	CcSEcCtD
Frovatriptan—Diarrhoea—Docetaxel—melanoma	0.000308	0.0011	CcSEcCtD
Frovatriptan—Dizziness—Docetaxel—melanoma	0.000297	0.00106	CcSEcCtD
Frovatriptan—Vomiting—Docetaxel—melanoma	0.000286	0.00102	CcSEcCtD
Frovatriptan—Headache—Docetaxel—melanoma	0.000282	0.00101	CcSEcCtD
Frovatriptan—Nausea—Docetaxel—melanoma	0.000267	0.000956	CcSEcCtD
Frovatriptan—HTR1D—Signaling Pathways—CSF2—melanoma	3.01e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF1—melanoma	3.01e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCR4—melanoma	2.99e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FOXO4—melanoma	2.99e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HDAC2—melanoma	2.99e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL2—melanoma	2.96e-05	0.000382	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNAQ—melanoma	2.96e-05	0.000382	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HPSE—melanoma	2.96e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CSF2—melanoma	2.95e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF1—melanoma	2.95e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—E2F1—melanoma	2.94e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CB—melanoma	2.93e-05	0.000378	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDGFRA—melanoma	2.91e-05	0.000376	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CUBN—melanoma	2.9e-05	0.000374	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL2—melanoma	2.9e-05	0.000374	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ITGB3—melanoma	2.88e-05	0.000372	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCA—melanoma	2.88e-05	0.000372	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—E2F1—melanoma	2.88e-05	0.000372	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CB—melanoma	2.87e-05	0.00037	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDGFRA—melanoma	2.85e-05	0.000368	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CG—melanoma	2.85e-05	0.000368	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SPP1—melanoma	2.83e-05	0.000365	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCA—melanoma	2.82e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ITGB3—melanoma	2.82e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAP2K2—melanoma	2.82e-05	0.000363	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—melanoma	2.82e-05	0.000363	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SDHD—melanoma	2.8e-05	0.000361	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BSG—melanoma	2.8e-05	0.000361	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CSPG4—melanoma	2.8e-05	0.000361	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SYK—melanoma	2.78e-05	0.000359	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SPP1—melanoma	2.77e-05	0.000357	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CD—melanoma	2.76e-05	0.000356	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAP2K2—melanoma	2.76e-05	0.000356	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—melanoma	2.76e-05	0.000355	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGFR—melanoma	2.73e-05	0.000352	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT3—melanoma	2.73e-05	0.000352	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ITGAV—melanoma	2.73e-05	0.000352	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPAM—melanoma	2.72e-05	0.00035	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL2—melanoma	2.69e-05	0.000347	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TERT—melanoma	2.68e-05	0.000346	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RAC1—melanoma	2.67e-05	0.000345	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL2—melanoma	2.63e-05	0.00034	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TERT—melanoma	2.63e-05	0.000338	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RAC1—melanoma	2.62e-05	0.000338	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—melanoma	2.56e-05	0.000331	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS1—melanoma	2.53e-05	0.000326	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAP2K1—melanoma	2.52e-05	0.000325	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S100B—melanoma	2.52e-05	0.000325	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—melanoma	2.51e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CD—melanoma	2.51e-05	0.000323	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—melanoma	2.45e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB4—melanoma	2.41e-05	0.000311	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	2.41e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—melanoma	2.4e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN2B—melanoma	2.39e-05	0.000308	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FN1—melanoma	2.36e-05	0.000304	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CD86—melanoma	2.31e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—melanoma	2.31e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FN1—melanoma	2.31e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH1—melanoma	2.31e-05	0.000298	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G6—melanoma	2.31e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—melanoma	2.3e-05	0.000296	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CD80—melanoma	2.26e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH1—melanoma	2.26e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APC—melanoma	2.26e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CG—melanoma	2.26e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KIT—melanoma	2.26e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NRAS—melanoma	2.26e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF1—melanoma	2.24e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CSF2—melanoma	2.24e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGF—melanoma	2.23e-05	0.000288	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CD80—melanoma	2.22e-05	0.000286	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APC—melanoma	2.21e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KIT—melanoma	2.21e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CG—melanoma	2.21e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NRAS—melanoma	2.21e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2—melanoma	2.21e-05	0.000285	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—E2F1—melanoma	2.2e-05	0.000283	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGF—melanoma	2.19e-05	0.000282	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CB—melanoma	2.19e-05	0.000282	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDGFRA—melanoma	2.17e-05	0.00028	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK3—melanoma	2.16e-05	0.000279	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ITGB3—melanoma	2.15e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCA—melanoma	2.15e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BRAF—melanoma	2.12e-05	0.000274	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK3—melanoma	2.12e-05	0.000273	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SPP1—melanoma	2.11e-05	0.000272	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAP2K2—melanoma	2.1e-05	0.000271	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—melanoma	2.1e-05	0.000271	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BRAF—melanoma	2.08e-05	0.000268	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—VCAN—melanoma	2.07e-05	0.000267	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—melanoma	2.07e-05	0.000267	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK1—melanoma	2.06e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—melanoma	2.06e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—melanoma	2.03e-05	0.000261	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK1—melanoma	2.02e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—melanoma	2.02e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2—melanoma	2.01e-05	0.000259	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TERT—melanoma	2e-05	0.000258	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAP2K1—melanoma	2e-05	0.000258	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RAC1—melanoma	1.99e-05	0.000257	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CD—melanoma	1.99e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—melanoma	1.97e-05	0.000254	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.96e-05	0.000253	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAP2K1—melanoma	1.96e-05	0.000252	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CD—melanoma	1.94e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—KRAS—melanoma	1.94e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—melanoma	1.93e-05	0.000248	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—melanoma	1.91e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—KRAS—melanoma	1.9e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF2—melanoma	1.9e-05	0.000245	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.89e-05	0.000244	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF2—melanoma	1.86e-05	0.00024	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—melanoma	1.83e-05	0.000236	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—melanoma	1.79e-05	0.00023	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MDM2—melanoma	1.78e-05	0.000229	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FN1—melanoma	1.76e-05	0.000227	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB2—melanoma	1.75e-05	0.000226	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP17A1—melanoma	1.75e-05	0.000226	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—melanoma	1.75e-05	0.000225	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MDM2—melanoma	1.74e-05	0.000225	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CB—melanoma	1.73e-05	0.000223	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.73e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH1—melanoma	1.72e-05	0.000222	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB2—melanoma	1.72e-05	0.000221	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.7e-05	0.00022	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CB—melanoma	1.69e-05	0.000219	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CD80—melanoma	1.69e-05	0.000218	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KIT—melanoma	1.68e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CG—melanoma	1.68e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APC—melanoma	1.68e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NRAS—melanoma	1.68e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGF—melanoma	1.67e-05	0.000215	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—melanoma	1.66e-05	0.000214	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRAS—melanoma	1.65e-05	0.000213	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNA11—melanoma	1.65e-05	0.000213	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—melanoma	1.63e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1B—melanoma	1.62e-05	0.000209	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRAS—melanoma	1.62e-05	0.000209	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FASN—melanoma	1.62e-05	0.000208	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK3—melanoma	1.61e-05	0.000208	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—melanoma	1.61e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—melanoma	1.59e-05	0.000205	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC5A5—melanoma	1.59e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1B—melanoma	1.59e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2—melanoma	1.59e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BRAF—melanoma	1.58e-05	0.000204	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—melanoma	1.58e-05	0.000204	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—melanoma	1.57e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—melanoma	1.56e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2—melanoma	1.56e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—melanoma	1.55e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—melanoma	1.55e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—melanoma	1.54e-05	0.000199	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNAQ—melanoma	1.54e-05	0.000198	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD44—melanoma	1.54e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK1—melanoma	1.54e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—melanoma	1.54e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CTNNB1—melanoma	1.53e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—melanoma	1.52e-05	0.000196	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—melanoma	1.5e-05	0.000194	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.5e-05	0.000194	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CTNNB1—melanoma	1.5e-05	0.000194	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1A—melanoma	1.5e-05	0.000193	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTEN—melanoma	1.5e-05	0.000193	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAP2K1—melanoma	1.49e-05	0.000192	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.49e-05	0.000192	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKB1—melanoma	1.49e-05	0.000192	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CD—melanoma	1.48e-05	0.000191	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—melanoma	1.47e-05	0.00019	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1B1—melanoma	1.47e-05	0.00019	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1A—melanoma	1.47e-05	0.000189	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	1.47e-05	0.000189	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTEN—melanoma	1.46e-05	0.000189	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—melanoma	1.46e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKB1—melanoma	1.46e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—KRAS—melanoma	1.45e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—melanoma	1.43e-05	0.000184	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF2—melanoma	1.42e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—melanoma	1.35e-05	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—melanoma	1.34e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NRAS—melanoma	1.33e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.33e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MDM2—melanoma	1.33e-05	0.000171	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—melanoma	1.32e-05	0.000171	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—melanoma	1.31e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB2—melanoma	1.31e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NRAS—melanoma	1.31e-05	0.000168	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.3e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.29e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK3—melanoma	1.28e-05	0.000165	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK3—melanoma	1.25e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—melanoma	1.24e-05	0.00016	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—melanoma	1.24e-05	0.00016	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRAS—melanoma	1.23e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—melanoma	1.22e-05	0.000157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK1—melanoma	1.22e-05	0.000157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—melanoma	1.22e-05	0.000157	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCB1—melanoma	1.21e-05	0.000156	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.21e-05	0.000156	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.2e-05	0.000155	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK1—melanoma	1.19e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—melanoma	1.19e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—melanoma	1.19e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2—melanoma	1.19e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—melanoma	1.18e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KRAS—melanoma	1.15e-05	0.000148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CTNNB1—melanoma	1.14e-05	0.000148	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KRAS—melanoma	1.12e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—melanoma	1.12e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1A—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PRKCA—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTEN—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKB1—melanoma	1.11e-05	0.000143	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ERCC2—melanoma	1.11e-05	0.000143	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—melanoma	1.09e-05	0.00014	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—melanoma	1.06e-05	0.000136	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—melanoma	1.03e-05	0.000133	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—melanoma	1.02e-05	0.000132	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—melanoma	1.01e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—melanoma	9.99e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—melanoma	9.98e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRAS—melanoma	9.95e-06	0.000128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRAS—melanoma	9.76e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRAS—melanoma	9.56e-06	0.000123	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK3—melanoma	9.53e-06	0.000123	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—melanoma	9.34e-06	0.00012	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—melanoma	9.27e-06	0.00012	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.17e-06	0.000118	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—melanoma	9.15e-06	0.000118	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK1—melanoma	9.07e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—melanoma	9.07e-06	0.000117	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CG—melanoma	8.74e-06	0.000113	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—melanoma	8.62e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KRAS—melanoma	8.57e-06	0.00011	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—melanoma	8.44e-06	0.000109	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—melanoma	8.44e-06	0.000109	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—melanoma	7.87e-06	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CD—melanoma	7.69e-06	9.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—melanoma	7.61e-06	9.82e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—melanoma	7.59e-06	9.78e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRAS—melanoma	7.28e-06	9.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—melanoma	6.97e-06	8.99e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CB—melanoma	6.7e-06	8.64e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—melanoma	6.64e-06	8.56e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—melanoma	6.43e-06	8.29e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTEN—melanoma	5.79e-06	7.46e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—melanoma	4.08e-06	5.27e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—melanoma	3.34e-06	4.3e-05	CbGpPWpGaD
